Investing In Tomorrow, Today – Why We Need To Look To The Future Of Clinical Trials

With 90% of clinical trials failing, soaring costs, and limited diversity, the traditional model is breaking down. Embracing these patient-centric shifts is no longer just an alternative; it is an imperative for delivering the next generation of life-saving therapies. The current model often overlooks diversity, leading to results that lack broad applicability, while development costs continue to climb toward the $2 billion mark. Transforming this ecosystem requires a strategic shift toward decentralized trial (DCT) elements and community-focused site networks. Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.